TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
Public ClinicalTrials.gov record NCT01170221. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of 6-Day Oral TR-701 Free Acid and 10-Day Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, double dummy, multicenter Phase 3 study of oral TR-701 FA 200 mg once daily for 6 days versus oral Zyvox® (linezolid) 600 mg every 12 hours for 10 days for the treatment of ABSSSI in adults. Approximately 75 to 100 sites globally will participate in this study. Patients with an ABSSSI caused by suspected or documented gram positive pathogen(s) at baseline will be randomized 1:1 to study treatment
Study identification
- NCT ID
- NCT01170221
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Industry
- Enrollment
- 667 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 14, 2010
- Primary completion
- Sep 29, 2011
- Completion
- Sep 29, 2011
- Last update posted
- Aug 28, 2018
2010 – 2011
United States locations
- U.S. sites
- 30
- U.S. states
- 12
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Trius investigator site 109 | Dothan | Alabama | 36301 | — |
| Trius Investigator site 130 | Anaheim | California | 92801 | — |
| Trius investigator site 118 | Anaheim | California | 92804 | — |
| Trius investigator site 129 | Buena Park | California | 90620 | — |
| Trius Investigator Site 103 | Chula Vista | California | 91911 | — |
| Trius Investigator Site 105 | La Mesa | California | 91942 | — |
| Trius investigator site 126 | Laguna Beach | California | 92651 | — |
| Trius investigator site 125 | Norwalk | California | 90650 | — |
| Trius Investigator Site 104 | Oceanside | California | 92056 | — |
| Trius investigator site 113 | Oxnard | California | 93030 | — |
| Trius investigator site 123 | Pasadena | California | 91105 | — |
| Trius Investigator Site 106 | Rolling Hills Estates | California | 90274 | — |
| Trius investigator site 111 | Torrance | California | 90501 | — |
| Trius investigator site 132 | Torrance | California | 90502 | — |
| Trius investigator site 127 | Fort Lauderdale | Florida | 33308 | — |
| Trius investigator site 135 | Hialeah | Florida | 33012 | — |
| Trius investigator site 101 | Columbus | Georgia | 31904 | — |
| Trius Investigator Site 102 | Savannah | Georgia | 31406 | — |
| Trius Investigator site 116 | Chicago | Illinois | 60637 | — |
| Trius Investigator Site 108 | Springfield | Illinois | 62701 | — |
| Trius investigator site 112 | Evansville | Indiana | 47714 | — |
| Trius Investigator Site 107 | Detroit | Michigan | 48202 | — |
| Trius investigator site 133 | Butte | Montana | 59701 | — |
| Trius investigator site 128 | Las Vegas | Nevada | 89109 | — |
| Trius investigator site 115 | Somers Point | New Jersey | 08244 | — |
| Trius investigator site 114 | Toledo | Ohio | 43608 | — |
| Trius investigator site 122 | Houston | Texas | 77002 | — |
| Trius investigator site 120 | Houston | Texas | 77005 | — |
| Trius investigator site 131 | Houston | Texas | 77081 | — |
| Trius Investigator site 121 | Houston | Texas | 77093 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01170221, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2018 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01170221 live on ClinicalTrials.gov.